Adverse events reported.

Only adverse events recorded in 3 patients or more have been listed in this table. A total of 196 AEs have been recorded, 179 of them were considered related to TG1042. All recorded adverse events were of grade 1 or 2 apart one grade 3 increase in blood lipase not considered related to TG1042.

本表格仅收录了发生于3名及以上受试者的不良事件。本次研究共记录到196例不良事件（Adverse Events，简称AEs），其中179例被判定与受试药物TG1042相关。除1例与TG1042无关的血清脂肪酶升高达3级外，其余所有记录的不良事件均为1级或2级。